Live Breaking News & Updates on Clinical development

Stay informed with the latest breaking news from Clinical development on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Clinical development and stay connected to the pulse of your community

Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung

Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Pennsylvania , United-states , David-chien , Suma-krishnan , Research-development , Nasdaq , Krystal-biotech-inc , Clinical-development-at-krystal-biotech , Drug-administration , Exchange-commission , Twitter , Biotech-announces-first-patient-dosed

BRII-835 + BRII-179 for Chronic Hepatitis B in 7MM: Market Size, Forecast, and Emerging Insights 2019-2032

Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "BRII-835 + BRII-179 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering."BRII-835 + BRII-179 Market Size, Forecast, and Emerging Insight - 2032" report provides comprehensive insights about BRII-835 + BRII-179 for chronic hepatitis B in the seven major markets and China. A detailed picture of the BRII-835 + BRII-179 for chronic hepatitis B in the 7MM, i.e., the United States, EU4 (Germany,

Germany , France , Japan , Italy , Taiwan , Hong-kong , Spain , China , Dublin , Ireland , United-states , United-kingdom

Pacylex CEO reveals Zelenirstat phase one results

Pacylex Pharmaceuticals Inc. has announced the presentation of phase 1 safety and efficacy findings for small molecule drug zelenirstat for cancer treatment.

United-states , Michael-weickert , Pacylex-pharmaceuticals , World-orphan-drug-congress-united-states , Stable-disease , Myeloid-leukemia , Acute-myeloid-leukemia , Fast-track , New-drug , Drink-administration , Pacylex-pharmaceutical , Clinical-development

NICE recommends Nexpovio for multiple myeloma

In a significant development for the multiple myeloma community, Menarini Stemline UK today welcomed the final draft guidance from the National Institute for Health and Care Excellence (NICE).

United-kingdom , Rick-coope , Neil-rabin , Menarini-stemline , Shelagh-mckinlay , Nelluri-geetha , University-college-london-hospitals , Myeloma-united-kingdom , Menarini-stemline-united-kingdom , Clinical-development , Reclinical-research , Ngredients

Kynos Therapeutics unveils KMO inhibitor trial results

Kynos Therapeutics Ltd, based in Edinburgh, UK, focuses on developing small molecule kynurenine 3-monooxygenase (KMO) inhibitors for inflammatory disorders.

United-kingdom , Jonathan-savidge , Damian-mole , Kynos-therapeutics , Innovate-united-kingdom , Clinical-development , Reclinical-research , Ngredients , Atient-centricity , Pis-active-pharmaceutical-ingredients- , Ata-management

New gene therapy for metachromatic leukodystrophy proves effective in mice

New gene therapy for metachromatic leukodystrophy proves effective in mice
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Paris , France-general- , France , Emilie-audouard , Methods-clinical-development , Paris-brain-institute , Molecular-therapy , Clinical-development ,

ProQR Therapeutics N : AGM 2024 Explanatory Notes

2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS PROQR THERAPEUTICS N.V.

Explanatory Notes to the Agenda

ProQR Therapeutics N.V. | Zernikedreef 9...

United-states , Belfast , United-kingdom , Amsterdam , Noord-holland , Netherlands , Germany , Dutch , Gerard-platenburg , James-shannon , Ernst-bayer , Martin-maier

Astria Therapeutics : - 2024 Proxy Statement

ASTRIA THERAPEUTICS, INC.

75 State Street, Suite 1400

Boston, MA 02109

NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS
...

Boston , Massachusetts , United-states , Joanne-beck , Hugh-cole , Jillc-milne , Gregg-lapointe , Wilmer-cutler-pickering-hale , Michael-kishbauch , Sunil-agarwal , Fred-callori , Ernst-young

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting

WALTHAM, Mass., April 22, 2024 -- TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment...

United-states , American , Michelle-matzko , Shazad-khokhar , Candace-perullo , Heather-savelle , Hannah-bader , Maghan-meyers , American-society-of-gene , Nasdaq , Tscan-therapeutics-inc , Globe-newswire-tscan-therapeutics-inc

Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034

/PRNewswire/ -- DelveInsight's Dry Age-related Macular Degeneration Market Insights report includes a comprehensive understanding of current treatment...

Japan , United-states , France , Spain , Germany , Italy , United-kingdom , American , Belite-bio , Ascentage-pharma , Exegenesis-bio , Iveric-bio